What a lot of naysayers seemed to have overlooked in their biased analysis of the survival data is the ff:-
(1) Conference at ASCO is a prestigious global event attended by the best medical and pharma research teams aimed at sharing their research.
(2) Oncosil’s presentation of its survival data has now been presented and published at this prestigious event in Chicago US.
(3) Oncosil’s survival data presentation would have been peer reviewed by independent researchers otherwise they could not present their findings.
(4) Now that Oncosil’s survival data has been presented, peer reviewed and published at ASCO the data can be presented to the upcoming meeting with BIS.
OSL Price at posting:
5.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)